LAVAL, Quebec, July 10, 2017 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today
announced that it plans to release second quarter 2017 financial
results on Tuesday, Aug. 8, 2017. The
Company will host a conference call and live webcast at
8:00 a.m. EDT to discuss the results
and provide a business update. All materials will be made available
on the investor relations portion of the corporate website before
the start of the conference call.
Conference Call Details
Date
|
Tuesday, Aug. 8,
2017
|
Time
|
8:00 a.m.
EDT
|
Webcast
|
http://ir.valeant.com/events-and-presentations
|
Participant Event
Dial-in
|
(877) 876-8393 (North
America)
|
|
(443) 961-0178
(International)
|
Participant
Passcode
|
35736021
|
Replay
Dial-in
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
Replay
Passcode
|
31833 (replay
available until Oct. 8, 2017)
|
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant can be found at www.valeant.com.
Investor
Contacts:
|
|
|
Arthur
Shannon
|
Elif
McDonald
|
|
arthur.shannon@valeant.com
|
elif.mcdonald@valeant.com
|
|
514-856-3855
|
514-856-3855
|
|
877-281-6642 (toll
free)
|
877-281-6642 (toll
free)
|
|
Media
Contact:
|
|
Lainie
Keller
|
|
lainie.keller@valeant.com
|
|
908-927-0617
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-announces-q2-2017-financial-results-date-and-conference-call-details-300485451.html
SOURCE Valeant Pharmaceuticals International, Inc.